Source:http://linkedlifedata.com/resource/pubmed/id/14613382
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2003-11-17
|
pubmed:abstractText |
To describe the trends in the utilization and expenditures of selective serotonin reuptake inhibitors (SSRIs) and venlafaxine within the Texas Medicaid program in 1999 and 2000; more specifically, to compare the use of citalopram with other SSRI agents and venlafaxine.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:issn |
1083-4087
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
492-8
|
pubmed:articleTitle |
Economic evaluation of citalopram use and expenditures among recipients in the Texas Medicaid program.
|
pubmed:affiliation |
Center for Pharmacoeconomic Studies, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA.
|
pubmed:publicationType |
Journal Article
|